JNK-c-Jun inhibitor AS601245, Purity ≥98%

Cat. No.: X23-10-ZQ950

JNK-c-Jun inhibitor AS601245, Purity ≥98%

Synonym: AS601245; 345987-15-7; AS-601245; 1,3-Benzothiazol-2-yl(2-((2-(3-pyridinyl)ethyl)amino)-4-pyrimidinyl)acetonitrile; 2-(Benzo[d]thiazol-2-yl)-2-(2-((2-(pyridin-3-yl)ethyl)amino)pyrimidin-4-yl)acetonitrile; 2-(1,3-Benzothiazol-2-yl)-2-[2-(2-pyridin-3-ylethylamino)pyrimidin-4-yl]acetonitrile; JNK-c-Jun inhibitor

  • MDL: MFCD07772196
  • CAS Number: 345987-15-7
  • Compound CID: 10109823
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
AS601245 is an inhibitor of c-jun N-terminal kinase (JNK) signaling. It targets hJNK1, hJNK2, and hJNK3.
Molecular Weight
372.45
Molecular Formula
C20H16N6S
Targets
hJNK1: 150 nM; hJNK2: 220 nM; hJNK3: 70 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
AS601245 can be used for research into the inhibition of JNK and its effects on inflammatory and apoptotic pathways.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.